Peptide hormone analogues of the formula X-V are provided herein, wherein X is a glucagon analogue or a GLP1 analogue, and V is a C-terminal extension amino acid sequence comprising at least four amino acid residues, at least three of said residues being His. Also provided herein are pharmaceutical compositions comprising said analogues, and methods of using said analogues for the treatment of conditions such as obesity and diabetes.
